Edition:
United Kingdom

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

61.80USD
4:09pm GMT
Change (% chg)

$2.10 (+3.52%)
Prev Close
$59.70
Open
$60.10
Day's High
$62.05
Day's Low
$60.00
Volume
29,229
Avg. Vol
176,339
52-wk High
$66.25
52-wk Low
$35.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.894
Jun '17 0.00 -0.817
Mar '17 0.00 -0.763
FY 2016 Dec '16 0.00 -0.871
Sep '16 0.00 -0.811
Jun '16 0.00 -0.867
Mar '16 0.00 -0.850
FY 2015 Dec '15 0.00 -0.766
Sep '15 0.00 -0.689
Jun '15 0.00 -0.727
Mar '15 0.00 -0.701
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 9 0.00 0.00 0.00 0.40
Quarter Ending Mar-18 4 0.00 0.00 0.00 --
Year Ending Dec-17 9 0.00 0.00 0.00 0.29
Year Ending Dec-18 10 23.30 33.30 3.45 47.31
Earnings (per share)
Quarter Ending Dec-17 7 -1.21 -0.52 -1.75 -0.63
Quarter Ending Mar-18 2 -0.59 -0.47 -0.71 -0.59
Year Ending Dec-17 8 -3.12 -2.48 -3.75 -2.50
Year Ending Dec-18 8 -2.41 -1.65 -3.10 -1.56
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 89.23 32.96
P/E High - Last 5 Yrs. -- 293.78 45.57
P/E Low - Last 5 Yrs. -- 94.62 24.35
Beta 1.06 0.85 0.89
Price to Sales (TTM) -- 86.57 5.25
Price to Book (MRQ) 10.34 13.59 5.40
Price to Tangible Book (MRQ) 10.34 13.47 6.74
Price to Cash Flow (TTM) -- 76.93 23.58
% Owned Institutions -- 6.31 1.29

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.27 1.49
Dividend 5 Year Growth Rate -- 1.88 5.23
Payout Ratio(TTM) -- 17.27 43.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 437.54 8.84
Sales (TTM) vs TTM 1 Yr. Ago -- 70.22 5.41
Sales - 5 Yr. Growth Rate -- 33.80 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.74 29.92 19.37
EPS (TTM) vs TTM 1 Yr. Ago -2.87 -- --
EPS - 5 Yr. Growth Rate -- 43.61 10.96
Capital Spending - 5 Yr. Growth Rate 152.98 41.13 15.32

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.69 2.20
Current Ratio (MRQ) 22.45 5.29 3.00
LT Debt to Equity (MRQ) 66.85 18.84 10.82
Total Debt to Equity (MRQ) 66.85 20.43 14.95
Interest Coverage (TTM) -39.77 -113.10 33.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.40 54.68
Gross Margin - 5 Yr. Avg. -- 51.61 52.15
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -233.74 15.51
Operating Margin (TTM) -- -434.91 9.27
Operating Margin - 5 Yr. Avg. -- -249.72 11.18
Pre-Tax Margin (TTM) -- -410.78 10.08
Pre-Tax Margin - 5 Yr. Avg. -- -249.03 11.61
Net Profit Margin (TTM) -- -412.33 6.37
Net Profit Margin - 5 Yr. Avg. -- -251.97 7.88
Effective Tax Rate (TTM) -- 23.97 23.20
Effective Tax Rate - 5 Yr. Avg. -- 19.27 24.03

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,590,626 876,720,280
Net Income/Employee (TTM) -1,130,063 3,388,768 103,150,938
Receivable Turnover (TTM) -- 21.68 5.78
Inventory Turnover (TTM) -- 2.02 3.35
Asset Turnover (TTM) 0.00 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.02 -0.31 11.10
Return on Assets - 5 Yr. Avg. -50.91 0.00 12.57
Return on Investment (TTM) -51.22 2.53 14.58
Return on Investment - 5 Yr. Avg. -55.60 3.09 16.46
Return on Equity (TTM) -128.08 3.17 16.09
Return on Equity - 5 Yr. Avg. -343.74 6.58 17.62
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -17.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aerie Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 258
Total Shares Held: 38,116,360
3 Mo. Net Change: 2,766,284
# New Positions: 29
# Closed Positions: 23
# Increased Positions: 134
# Reduced Positions: 79
# Net Buyers: 55
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.